Cat. #157666
PL3 Peptide
Cat. #: 157666
Sub-type: Synthetic Peptide
Availability: Please enquire for quantities and pricing
Target: Tenascin-C C domain (TNC-C)
Function: Marker
This fee is applicable only for non-profit organisations. If you are a for-profit organisation or a researcher working on commercially-sponsored academic research, you will need to contact our licensing team for a commercial use license.
Contributor
Inventor: Prakash Lingasamy ; Tambet Teesalu
Institute: University of Tartu
Tool Details
*FOR RESEARCH USE ONLY (for other uses, please contact the licensing team)
- Tool name: PL3 Peptide
- Alternate name: PL3, Tenascin-C C domain specific peptide
- Research fields: Cancer;Cell biology
- Tool sub type: Synthetic Peptide
- Sequence: AGRGRLVR
- Cellular tissue localisation: PL3 is specific to tenascin-C C domain (TNC-C)
- Target: Tenascin-C C domain (TNC-C)
- Description: Tenascin-C C domain (TNC-C) is not present in the extracellular matrix of adult tissues but it is up-regulated in tumours and malignant tissues. It has previously been used as a target for antibody-based therapies. PL3 is a specific peptide which has enhanced affinity to bind to TNC-C so PL3 may be useful as an affinity ligand for delivery of diagnostic compound into solid tumours.
- Function: Marker
- Expression system: Synthetic
Handling
- Shipping conditions: Dry Ice
Target Details
- Target: Tenascin-C C domain (TNC-C)
Related Tools
- Related tools: PL1 peptide
